| Name: | Clindamycin phosphate EP Impurity L |
| Catalogue No. | VE005873 |
| CAS No. | 620181-05-7 |
| Molecular Formula | C18H34ClN2O8PS |
| Molecular Weight | 504.96 |
| Status | In-stock |
| IUPAC Name | Methyl 7-chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-4-propylpyrrolidin-2-yl] carbonyl]amino]-2-O-phosphono-1-thio-D-erythro-α-D-galacto-octopyranoside |
| Appearance | Pale Yellow Solid |
| Description | Clindamycin phosphate EP Impurity L (CAS No: 620181-05-7) is a degradation product of Clindamycin. Clindamycin is an antimicrobial agent which is evaluated in the treatment of anaerobic infections. Clindamycin is a potent drug for the treatment of infections involving anaerobes and gram-positive cocci. |
| References | Consultation Documents. apps.who.int/iris/bitstream/handle/10665/331019/DI303-414-476-eng.pdf. Accessed 7 Oct. 2021. Kasten, Mary Jo. “Clindamycin, Metronidazole, and Chloramphenicol.” Mayo Clinic Proceedings, vol. 74, no. 8, Aug. 1999, pp. 825–33, https://doi.org/10.4065/74.8.82 |
